Human medicines European public assessment report (EPAR): Celldemic, influenza vaccine (surface antigen, inactivated, prepared in cell cultures), Date of authorisation: 19/04/2024, Status: Authorised

Human medicines European public assessment report (EPAR): Zynyz, retifanlimab, Date of authorisation: 19/04/2024, Status: Authorised

CAT quarterly highlights and approved ATMPs - February - April 2024

Quality of medicines questions and answers: Part 1

Stability testing for applications for variations to a marketing authorisation for veterinary medicinal products - Scientific guideline

Guideline on stability testing for applications for variations to a marketing authorisation for veterinary medicinal products

Human medicines European public assessment report (EPAR): Mirapexin, pramipexole, Date of authorisation: 23/02/1998, Revision: 42, Status: Authorised

Concept paper on revision of the Guideline on Risk Assessment of Medicinal Products on Human Reproduction and Lactation: from Data to Labelling

List of eligible industry stakeholder organisations